Suppr超能文献

心房颤动的药物和非药物管理。

Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation.

机构信息

Cardiovascular Disease, Summa Health System, NEOMED University, Akron City Hospital, 95 Arch Street, Suite 300, Akron, OH 44304, USA.

Section of Pacing and Electrophysiology, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue/J2, Cleveland, OH 44195, USA.

出版信息

Med Clin North Am. 2019 Sep;103(5):835-846. doi: 10.1016/j.mcna.2019.04.004. Epub 2019 Jul 1.

Abstract

Atrial fibrillation (AF) is the most common arrhythmia and its management may be organized into risk stratification and/or treatment of heart failure, stroke prevention, and symptom control. At the core of symptom control, treatment is tailored to either allow AF continue with controlled heart rates, so-called rate control, versus restoring and maintaining sinus rhythm or rhythm control. Rate control strategies mainly use rate-modulating medications, whereas rhythm control treatment includes therapy aimed at restoring sinus rhythm, including pharmacologic and direct current cardioversion, as well as maintenance of sinus rhythm, including antiarrhythmic medications and ablation therapy.

摘要

心房颤动(AF)是最常见的心律失常,其管理可分为风险分层和/或心力衰竭治疗、预防中风以及症状控制。在症状控制的核心,治疗方法是根据控制心率,即所谓的心率控制,与恢复和维持窦性节律或节律控制来进行调整。心率控制策略主要使用调律药物,而节律控制治疗包括旨在恢复窦性节律的治疗,包括药物和直流电复律,以及维持窦性节律,包括抗心律失常药物和消融治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验